Our data showed the improved anti-glioma effect of the armed oncolytic adenovirus, Delta-24-GREAT (Glucocorticoid Receptor Enhanced Activity of T cells), and the increased frequency and activation of T cells. The gene discussed is NR3C1; the disease is central nervous system cancer.